Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections; dilute hydrochloric acid - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - ropivacaine hydrochloride, quantity: 7.5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - surgical anaesthesia (adults and children over 12 years of age),? epidural block for surgery including caesarean section,? intrathecal anaesthesia,? field block (minor nerve block and infiltration),? major nerve block,analgesia (adults and children over 12 years of age),? continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain,? field block (minor nerve block and infiltration),? continuous peripheral nerve block infusion or intermittent injections for post operative pain management,? continuous wound infusion for postoperative pain management (adults only),analgesia (children aged 0 - 12 years),? caudal epidural block in neonates (> 37 weeks gestation and over 2,500 g weight), infants and children up to and including 12 years,? continuous epidural infusion in infants (> 30 days and over 2,500 g weight) and children up to and including 12 years,? peripheral nerve block in children aged 1 up to and including 12 years,for peri- and postoperative pain management.,there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections and for continuous wound infusion support the use for up to 48 hours only).

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ropivacaine hydrochloride, quantity: 7.5 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - surgical anaesthesia (adults and children over 12 years of age) epidural block for surgery including caesarean section. intrathecal anaesthesia. field block (minor nerve block and infiltration). major nerve block. analgesia (adults and children over 12 years of age) continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. field block (minor nerve block and infiltration). continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0-12 years). caudal epidural block in neonates (>37 weeks gestation and over 2500g weight), infants and children up to and including 12 years. continuous epidural infusion in infants (>30 days and over 2500g weight) and children up to and including 12 years. peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 5 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium metabisulfite; hydrochloric acid; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - ropivacaine hydrochloride 5 mg/ml equivalent to ropivacaine 4.43 mg/ml;   - solution for injection - 5 mg/ml - active: ropivacaine hydrochloride 5 mg/ml equivalent to ropivacaine 4.43 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - analgesia (adults and children over 12 years of age) · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain · field block (minor nerve block and infiltration) · continuous peripheral nerve block infusion or intermittent injections for postoperative pain management · continuous wound infusion for postoperative pain management (adults only) analgesia (children aged 0-12 years of age) · caudal epidural block in neonates (>37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years · continuous epidural infusion in infants (>30 days and over 2500 g weight) and children up to and including 12 years · peripheral nerve block in children aged 1 up to and including 12 years for peri- and postoperative pain management

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - ropivacaine hydrochloride 7.5 mg/ml equivalent to ropivacaine 6.64 mg/ml;   - solution for injection - 7.5 mg/ml - active: ropivacaine hydrochloride 7.5 mg/ml equivalent to ropivacaine 6.64 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - analgesia (adults and children over 12 years of age) · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain · field block (minor nerve block and infiltration) · continuous peripheral nerve block infusion or intermittent injections for postoperative pain management · continuous wound infusion for postoperative pain management (adults only) analgesia (children aged 0-12 years of age) · caudal epidural block in neonates (>37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years · continuous epidural infusion in infants (>30 days and over 2500 g weight) and children up to and including 12 years · peripheral nerve block in children aged 1 up to and including 12 years for peri- and postoperative pain management

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - ropivacaine hydrochloride, quantity: 75 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - surgical anaesthesia (adults and children over 12 years of age); epidural block for surgery including caesarean section; intrathecal anaesthesia; field block (minor nerve block and infiltration); major nerve block. analgesia (adults and children over 12 years of age); continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain; field block (minor nerve block and infiltration); continuous peripheral nerve block infusion or intermittent injections for post operative pain management; continuous wound infusion for postoperative pain management (adults only). analgesia (children aged 0 - 12 years); caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years. continous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years; peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine hydrochloride for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections and for continuous wound infusion support the use for up to 48 hours only).

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of inflitration and nerve block techniques.